Ken Suzuki Joins Accenture as Principle Director for Life Sciences

Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life Science, bringing extensive experience in the pharmaceutical industry, healthcare consulting and commercial strategy to the role.

Suzuki has more than 30 years of experience across pharmaceuticals and life sciences consulting. His areas of expertise include product launch strategy, brand management, market access and pricing, new product planning, forecasting, marketing intelligence and data analytics. He has also worked on digital marketing initiatives, including the introduction of marketing automation.

Before joining Accenture in October 2026, Suzuki worked at Baycurrent Consulting, where he held senior roles in healthcare and life sciences consulting. His work included advising on new-business development, market entry and scalability, digital initiatives, and the development of technology-based healthcare solutions.

- Advertisement -

Earlier in his career, Suzuki spent more than two decades at Astellas Pharma and its affiliated organizations. His responsibilities included regional commercial leadership across Japan and Asia Pacific, business feasibility operations, marketing intelligence analytics, communication strategy and global marketing strategy. He was also involved in initiatives exploring healthcare solutions beyond conventional pharmaceuticals.

Also Read: MRSO Launches Security Support Service for Healthcare

Suzuki’s appointment comes as pharmaceutical and life sciences companies face growing pressure to connect scientific innovation with commercial outcomes, patient needs and digital capabilities. Organizations are increasingly exploring data analytics, digital therapeutics, software as a medical device (SaMD) and technology-enabled healthcare services alongside traditional drug development.

His background across pharmaceutical marketing, market access, new-business planning and digital initiatives aligns with the range of commercial and transformation challenges facing the life sciences sector.

At Accenture, Suzuki takes on a leadership role focused on industry and enterprise life sciences, bringing experience from pharmaceutical operations and consulting to the company’s work in the healthcare sector.